Market Pulse: Saatvik Green Energy Leaps on Huge SECI Order as Aurobindo Pharma Tumbles After FDA Observation

Dalal Street was anything but dull on September 16, 2026. While the broader market kept feeling the pressure – the Nifty Midcap 100 stayed in the red and the Smallcap 100 slipped about 0.6% – a few individual stocks managed to grab the spotlight.

First up, Saatvik Green Energy saw its shares climb roughly 5% after the firm announced a Rs 1,041.63 crore order from the Solar Energy Corporation of India (SECI). The deal, which involves supplying solar PV modules, was enough to spark a modest rally, with investors apparently betting on the renewable‑energy wave that’s still gathering steam.

On the flip side, Aurobindo Pharma endured a near‑2% decline after the U.S. Food and Drug Administration (USFDA) inspected Unit‑II of its subsidiary, Apitoria Pharma, in Telangana. The inspection, conducted between September 7 and 15, resulted in a single procedural observation – nothing catastrophic, but enough to raise eyebrows and dent sentiment.

Other names made headlines too. Sonata Software slipped about 2% despite its subsidiary, Sonata Information Technology, signing a five‑year strategic collaboration with Amazon Web Services to push cloud adoption across Indian enterprises. Meanwhile, India Pesticides jumped 5% after winning Technical Equivalence approval for an insecticide in the UK and securing registration for a herbicide in Argentina.

VIP Industries added roughly 2% as investors awaited a board meeting slated for September 18, where the company may propose raising capital through equity, debt, or convertible securities – a move that could provide fresh funding for its expanding operations.

Sector‑wise, the IT index fell 1% and pharma slid 0.5%, while FMCG, media, PSU banks and realty each managed modest gains of over 1%. Market breadth remained weak on the BSE, with just 1,496 stocks advancing against 2,222 declining and 168 unchanged.